MTOR and melanoma: The dysregulated paracrine renin–angiotensin system, especially through the binding of ATII to AT1R, may enhance melanoma CSC properties by activating the Ras/RAF/MAPK/ERK and PI3K/AKT/mTOR pathways, ultimately leading to the increased expression of CSC markers and self-renewal capacity.